Business
Ventripoint Announces Appointment of Justin Leushner as CEO and Changes to the Board of Directors
(via TheNewswire) Toronto, Ontario - TheNewswire - November 4, 2019 - Vent...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Announces Appointment of Justin Leushner as CEO and Changes to the Board of Directors(via TheNewswire)\n \n \nToronto, Ontario - TheNewswire - November 4, 2019 - Ventripoint Diagnostics Ltd. (\"Ventripoint\" or the \"Company\") (TSXV:VPT) (OTC:VPTDF) is pleased to announce it has appointed Justin Leushner as CEO of Ventripoint. Dr. George Adams has resigned as CEO and has been elected as Chairman of the Board of Directors of Ventripoint. \n\n\n \nMr. Leushner's appointment is a reflection of the Company's current state: ready for commercial success. Ventripoint is poised for major growth and Justin's unique leadership experience in life sciences and biotechnology will help ensure the Company's future success. There is enormous opportunity for Ventripoint and all at the Company look forward to having Mr. Leushner at the helm. \n\n\n \n\"With regulatory approvals received for the VMS+ 3.0 in Canada, Europe and the USA, I have accomplished my goal as CEO of leading the team to create the best cardiac analysis device in the market. It was very rewarding to hear one cardiologist at a leading hospital say he could get an MRI done in 20 minutes but would rather use the VMS+ 3.0. Another one said, \"This is like a microwave oven - once you use it, you cannot imagine not having one.\" I would like to thank our shareholders for your long-term support and ask your support for Justin as he leads the next phase of commercialization and value creation,\" stated Dr. Adams, Chairman of the Board. \n\n\n \n\"Those of us who have worked for so many years with George know that the shareholders, executive team and employees owe him a huge debt of gratitude for his extraordinary efforts on behalf of the Company. All of us at Ventripoint wish him well and thank him for his leadership, guidance, inspiration and support as CEO,\" said Don Segal, Ventripoint Director.\n\n\n \n\"We would like to thank Dr. George Adams for his dedication to the Ventripoint technology as CEO for the past 9 years. I am excited to have the opportunity to lead Ventripoint in this new chapter. Working with the strong management and clinical team over the past few months, it is clear that the Company is now ready to achieve its full potential as we begin selling our new system to hospitals and cardiac centers worldwide,\" commented Mr. Leushner, Ventripoint CEO. \n\...